Company intelligence / Profile preview

Biomnigene

Besançon, Bourgogne-Franche-Comté, Francebiomnigene.fr ↗

Ownership: Private
Development stage: Other

Overview

Biomnigene offers advanced molecular biology and genomic analysis services including DNA/RNA extraction, PCR/qPCR, Sanger and next-generation sequencing for research, industrial, environmental, agri-food, and medical applications. The company specializes in microbiome analysis and monoclonal antibody sequencing using high-throughput Illumina platforms. It supports clients from sample processing to bioinformatics data interpretation with rapid turnaround times.

Modalities: DNA/RNA extraction and analysis (service)PCR-based analysis (service)Next-generation sequencing (NGS) (service)Sanger sequencing (service)Monoclonal antibody sequencing (service)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Biomnigene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomnigene.

Explore the full profile